Drug Topics
JANUARY 10, 2024
The estimated efficacy of the vaccine against documented infection for children and adolescents during the Omicron wave was 74.3% and 85.5%, respectively.
Pharmacy Times
JANUARY 10, 2024
Community pharmacists have a unique opportunity to counsel caregivers on liquid OTC children’s products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 10, 2024
Amid ongoing concerns over conflicts of interest, a new study found that 60% of the physicians who served as panel and task force members for the American Psychiatric Association’s official manual of psychiatric disorders received payments from industry totaling more than $14 million. And the authors argue the findings raise questions about the editorial independence of the reference book.
Pharmacy Times
JANUARY 10, 2024
The 10-year cumulative incidence rate was equally high between both cohorts of smoking and nonsmoking individuals.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
JANUARY 10, 2024
New weight loss medications like Ozempic and Wegovy have garnered a lot of attention in the past year, but they aren’t always easy to get, especially for young people. Instead, teens surfing TikTok often see other options that don’t even require a doctor’s note. Berberine, for example, is a supplement that has been referred to online as “nature’s Ozempic.
Pharmacy Times
JANUARY 10, 2024
Claire Biermaas, President of Corporate Partnerships at Cencora, discussed how her team is working with their partners to address new challenges amid the shifting landscape of pharmacy.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
JANUARY 10, 2024
In the wake of the COVID-19 pandemic, virtual care and digital health tools are more popular than ever. | Elevance Health is launching a new initiative that aims to put smartphones in the hands of Medicaid members who otherwise cannot connect to virtual services.
STAT
JANUARY 10, 2024
More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes. The results follow the recent market launch of Veozah, Astellas Pharma’s groundbreaking non-hormonal treatment for hot flashes, which was approved by the U.S.
Pharmacy Times
JANUARY 10, 2024
Eli Lilly & Co. has been one of the first companies to address the off-label use of their tirzepatide drugs, Mounjaro and Zepbound, for cosmetic weight loss.
STAT
JANUARY 10, 2024
LONDON — A decade ago, the U.K. launched its 100,000 Genomes Project, a major research endeavor that involved sequencing the DNA of that many people to discover how our genes shape our health. But the initiative wasn’t just focused on sequencing our regular DNA. One arm of the project also entailed decoding the genomes of some participants’ tumors.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JANUARY 10, 2024
Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria. Learn more about their innovative vaccine development process and their commitment to creating a healthier future.
STAT
JANUARY 10, 2024
SAN FRANCISCO — The promise of genome editing has given rise to potentially curative medicines for rare, life-threatening diseases that generally affect small numbers of patients. But since Verve Therapeutics was founded in 2018, it’s had a wider aperture: using the molecular tools of genome editing to go after the most common cause of death in the world.
Fierce Pharma
JANUARY 10, 2024
With a late-stage pipeline spanning more than 120 clinical trials and a firm grasp of five major disease areas, AstraZeneca appears confident heading into 2024. | In AZ's push to reach industry-leading growth by 2030, confidence is key, chief financial officer Aradhana Sarin said at the J.P. Morgan Healthcare Conference. Besides that goal, the company wants to be a top-3 player in its five disease areas of focus.
Pharmacy Times
JANUARY 10, 2024
Investigators also found that those with HIV were more likely to be readmitted to the hospital within 30 days of cardiac surgery.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JANUARY 10, 2024
A lawsuit between a large hospital system and a dominant vendor that works for health insurance companies is getting a lot more heated — with one party calling the other an “economic parasite.” The suit, between nonprofit hospital giant AdventHealth and MultiPlan, is now even attracting rare interest from the nation’s biggest hospital lobbyists.
Pharmacy Times
JANUARY 10, 2024
This combination regimen, which was compared to once-daily insulin glargine U100 with insulin aspart, had also demonstrated a safe and well-tolerated profile with mild AEs.
pharmaphorum
JANUARY 10, 2024
On Day 2 of the JP Morgan 2024 conference, there are exciting presentations from companies such as Daiichi-Sankyo, Recode Therapeutics, and Vir Biotech. The focus was on innovative advancements in healthcare and the contributions of women in the industry. Learn more about the highlights of this day.
Pharmacy Times
JANUARY 10, 2024
Gabriel Hinojosa, PharmD, BCOP, reviews head-to-head comparisons in multiple myeloma regimens and evaluates efficacy and safety implications in treatment selection.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
JANUARY 10, 2024
Ensuring R&D investments deliver maximum potential: Notable ways to enhance clinical development strategy and design Mike.
Pharmacy Times
JANUARY 10, 2024
Adults diagnosed with coronary heart disease before age 45 have an especially increased risk of developing dementia, Alzheimer disease, and vascular dementia.
pharmaphorum
JANUARY 10, 2024
Explore the latest trends and projections in life sciences real estate, including the impact of digital health, the evolving needs of laboratory facilities, and the future of real estate in this sector. Stay ahead of the curve with insights into the industry's future.
PharmExec
JANUARY 10, 2024
Snyder discusses potential trends for various technologies, including AI, digital therapeutics, and virtual reality.
pharmaphorum
JANUARY 10, 2024
Discover the top 5 pharma marketing trends to watch out for in 2024. From personalised marketing strategies to the power of video and omnichannel communication, explore how patient-centric approaches and generative AI are shaping the future of pharmaceutical marketing.
STAT
JANUARY 10, 2024
Good morning, everyone, and how are you today? We are doing just fine, thank you. Given that this is already the middle of the week and we have survived this far, no reason not to continue, yes? Just consider the alternatives. In fact, this modest accomplishment calls for celebration. So please join us in quaffing a ritual cup of needed stimulation.
pharmaphorum
JANUARY 10, 2024
AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour subcutaneous infusion therapy for the neurodegenerative disorder.
Fierce Pharma
JANUARY 10, 2024
Age 37 might be old for a “coming-out party,” but that’s the situation for Alkermes at this year’s J.P. Morgan Healthcare Conference, chief operating officer Blair Jackson said in an interview. | Age 37 might be old for a “coming-out party,” but that’s the situation for Alkermes at this year’s J.P. Morgan Healthcare Conference, said chief operating officer Blair Jackson.
Drug Topics
JANUARY 10, 2024
Results from a meta-analysis demonstrated that magnesium supplementation was able to decrease fasting glucose levels and improve insulin resistance.
Fierce Pharma
JANUARY 10, 2024
In his first presentation as the new CEO of BioMarin, Alexander Hardy left no doubt about his mission for the rare and genetic disease specialist. | In his first presentation as the new CEO of BioMarin, Alexander Hardy left no doubt about his mission for the rare and genetic disease specialist. The top priority for the former Genentech CEO is to accelerate and maximize the commercial potential of dwarfism drug Voxzogo.
pharmaphorum
JANUARY 10, 2024
Precision BioSciences licenses non-cancer uses of its allogeneic CAR-T therapy azer-cel to TG Therapeutics as it pivots to in vivo applications of its gene-editing technology
Fierce Pharma
JANUARY 10, 2024
San Francisco—Bluebird bio’s 40% list-price | Bluebird bio’s 40% list-price premium for Lyfgenia compared with Vertex and CRISPR Therapeutics’ sickle cell disease drug surprised many industry watchers last month. But bluebird CEO Andrew Obenshain argues the prices for the gene therapy rivals shouldn’t be compared directly.
Hospital Pharmacy Europe
JANUARY 10, 2024
The Royal Pharmaceutical Society (RPS) is calling on pharmacists across the UK to engage with their MPs and local prospective parliamentary candidates to help ensure pharmacy is part of health service debates ahead of the next general election. It has developed a pledge, entitled ‘Pharmacy Matters’, asking prospective candidates to sign a ‘prescription for the nation’s health’, which forms part of the Society’s wider general election manifesto.
pharmaphorum
JANUARY 10, 2024
Quantum computing and artificial intelligence specialist SandboxAQ has bought Good Chemistry in a deal focused on drug discovery and material science
The Checkup by Singlecare
JANUARY 10, 2024
With the popularity of semaglutide injectables continually growing, people are turning to medication to aid in weight loss more than ever. Although medications, Wegovy and Mounjaro , are proven to help patients lose weight , they can often be prohibitively expensive as many insurance providers do not offer coverage. Enter berberine, a plant-based supplement sometimes called “nature’s Ozempic” that is trending on social media as an alternative to weight-loss drugs.
Expert insights. Personalized for you.
219 
Let's personalize your content